Advate 250 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung - Set(s) Swissmedic Key 56352001 Registration Holder Takeda Pharma AG Name Advate 250 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung Date of registration 17.02.2004 Introduction of Sequence 17.02.2004 ATC-Classification Coagulation Factor Viii (B02BD02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 06.01.10. Show package size Set(s) Index Therapeuticus (Swissmedic) 06.01.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price 321.25 Deductible k.A. Consumer price 361.25 Feedback FB GTIN 7680563520011 Medication Code Biotechnologika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: octocogum alfa 250 U.I., trehalosum dihydricum, histidinum, trometamolum, natrii chloridum corresp. natrium 10.35 mg, calcii chloridum dihydricum, polysorbatum 80, mannitolum, glutathionum, pro vitro.
Solvens: aqua ad iniectabile 5 ml. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Lyophilisate and solvent Excipiens Active Agent Dose Blutgerinnungsfaktor Viii Vom Menschen 250 UI
Inactive agents Calcium Chloride Histidine Mannitol Sodium Chloride Polysorbatum 80 Trometamol
Source Data was imported : 11.07.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
